• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The effect of chemotherapy on acute leukemia in the human.

作者信息

FREIREICH E J, GEHAN E A, SULMAN D, BOGGS D R, FREI E

出版信息

J Chronic Dis. 1961 Dec;14:593-608. doi: 10.1016/0021-9681(61)90118-7.

DOI:10.1016/0021-9681(61)90118-7
PMID:13894982
Abstract
摘要

相似文献

1
The effect of chemotherapy on acute leukemia in the human.化疗对人类急性白血病的影响。
J Chronic Dis. 1961 Dec;14:593-608. doi: 10.1016/0021-9681(61)90118-7.
2
Chemotherapy of acute leukemia in Japan.
Cancer Chemother Rep. 1961 Jul;13:141-4.
3
Factors influencing patient selection for chemotherapy studies of acute leukemia.
J Chronic Dis. 1962 Mar;15:251-7. doi: 10.1016/0021-9681(62)90007-3.
4
Factors influencing patient selection for chemotherapy studies of acute leukemia.
Cancer Chemother Rep. 1962 Feb;16:79-87.
5
Investigations in acute leukemia.
Natl Cancer Inst Monogr. 1960 Aug;3:149-68.
6
Chemotherapeutic control of acute leukemia. III, Miscellaneous agents.急性白血病的化疗控制。III，其他药物。
Am J Pharm Sci Support Public Health. 1961 Nov;133:395-400.
7
Cyclophosphamide (Cytoxan) in acute leukemia.
Cancer Chemother Rep. 1962 Feb;16:167-71.
8
A clinical trial of sarcolysin in acute leukemia.
Cancer Chemother Rep. 1961 Jun;12:153-5.
9
Cyclophosphamide (cytoxan) in acute leukemia, preliminary report.
Cancer Chemother Rep. 1960 Jul;8:116-9.
10
Remission maintenance in acute leukemia: a new specific experimental design. Studies by the acute leukemia group B.
J Chronic Dis. 1962 Mar;15:269-72. doi: 10.1016/0021-9681(62)90010-3.

引用本文的文献

1
The origins of the definition of complete remission in acute myeloid leukemia.急性髓系白血病完全缓解定义的起源。
Haematologica. 2025 Feb 1;110(2):268-269. doi: 10.3324/haematol.2024.286629.
2
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia.在既往未经治疗的成年急性髓系白血病患者中，使用低甲基化剂联合维奈克拉治疗的最佳反应结果。
Ann Hematol. 2025 Jan;104(1):307-315. doi: 10.1007/s00277-024-05976-6. Epub 2024 Sep 7.
3
Precision medicine in AML: overcoming resistance.
精准医学治疗 AML：克服耐药性。
Int J Hematol. 2024 Oct;120(4):439-454. doi: 10.1007/s12185-024-03827-8. Epub 2024 Aug 1.
4
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts.急性髓系白血病完全缓解（CR）伴部分血液学恢复（CRh）的临床评估：来自七个队列的7235例患者报告
Leukemia. 2024 Feb;38(2):389-392. doi: 10.1038/s41375-024-02143-8. Epub 2024 Jan 23.
5
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel.采用低强度治疗的急性髓系白血病患者的可测量残留病监测：ELN-DAVID 专家小组的路线图。
Am J Hematol. 2023 Dec;98(12):1847-1855. doi: 10.1002/ajh.27087. Epub 2023 Sep 6.
6
Response Rates as Predictors of Overall Survival: A Meta-Analysis of Acute Myeloid Leukemia Trials.缓解率作为总生存期的预测指标：急性髓系白血病试验的荟萃分析
J Cancer. 2017 Jun 3;8(9):1562-1567. doi: 10.7150/jca.18686. eCollection 2017.
7
[Prognostic significance of blood count at the time of achieving morphologic leukemia-free state in adults with acute myeloid leukemia].[急性髓系白血病成人患者达到形态学无白血病状态时血细胞计数的预后意义]
Zhonghua Xue Ye Xue Za Zhi. 2017 Mar 14;38(3):185-191. doi: 10.3760/cma.j.issn.0253-2727.2017.03.003.
8
Measurable residual disease testing in acute myeloid leukaemia.急性髓系白血病的可测量残留病检测。
Leukemia. 2017 Jul;31(7):1482-1490. doi: 10.1038/leu.2017.113. Epub 2017 Apr 7.
9
Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia.阿糖胞苷化疗敏感性相关基因表达特征与细胞遗传学正常的急性髓系白血病生存情况的关联
Oncotarget. 2017 Jan 3;8(1):1529-1540. doi: 10.18632/oncotarget.13650.
10
Acute Myeloid Leukemia: How Do We Measure Success?急性髓系白血病：我们如何衡量治疗成效？
Curr Hematol Malig Rep. 2016 Dec;11(6):528-536. doi: 10.1007/s11899-016-0346-x.